Di(2-ethylhexyl) phthalate (DEHP), a widely used plasticizer, is a ubiquitous environmental contaminant and may act as an endocrine disruptor. Early life exposures to DEHP may result in anti-androgenic effects, impairing the development of the male reproductive tract. However, data on the long-lasting consequences of such DEHP exposures on adult male reproductive function are still rare and discrepant. Previously, we identified 2 novel plasticizers, 1,4-butanediol dibenzoate (BDB) and dioctyl succinate (DOS), as potential substitutes for DEHP that did not reproduce classically described endocrine disrupting phenotypes in prepubertal male offspring after maternal exposure. Here, we investigated the consequences of in utero and lactational exposure to BDB and DOS on adult male rat reproductive function in a comparative study with DEHP and a commercially available alternative plasticizer, 1,2-cyclohexane dicarboxylic acid diisononyl ester (DINCH). Timed pregnant Sprague Dawley rats were gavaged with vehicle or a test chemical (30 or 300 mg/kg/day) from gestation day 8 to postnatal day 21. While DEHP exposure (300 mg/kg/day) significantly increased epididymal weight in the adult, exposure to DINCH, BDB, or DOS did not affect reproductive organ weights, steroid levels, or sperm quality. Using a toxicogenomic microarray approach, we found that adult testicular gene expression was affected by exposure to the higher dose of DEHP; transcripts such as Nr5a2, Ltf, or Runx2 were significantly downregulated, suggesting that DEHP was targeting estrogen signaling. Lesser effects were observed after treatment with either DINCH or BDB. DOS exposure did not produce such effects, confirming its potential as a responsible substitute for DEHP.
Phthalates are plasticizing agents used as emollients, matrices, solvents, and excipients in numerous industrial applications (Heudorf et al., 2007) . Among them, di(2-ethylhexyl) phthalate (DEHP) is the most commonly used additive to provide flexibility to polyvinyl chloride (PVC) and is found in products such as construction materials, household products, toys, cosmetics, food packaging, and medical tubing (Schettler, 2006) . Since phthalates are not covalently bound to their supports, they leach into the environment over time (Erythropel et al., 2014; Thomas and Thomas, 1984) , resulting in widespread human exposure (Hauser and Calafat, 2005; Koch et al., 2003; Wittassek et al., 2011) . Biomonitoring studies reveal their presence in several body fluids, including blood, urine (Silva et al., 2004a) , semen (Duty et al., 2003) , amniotic fluid (Silva et al., 2004b) , umbilical cord blood (Latini et al., 2003) , and breast milk (Calafat et al., 2004) .
Over the past few decades, phthalates, including DEHP, have been established to act as endocrine disrupting compounds, producing adverse effects in various in vitro and in vivo models in both males (Albert and J egou, 2014) and females (Hannon and Flaws, 2015) . Numerous studies have demonstrated the effects of in utero and lactational exposure to these agents on the developing fetus, a sensitive target for chemical insults (Skakkebaek et al., 2001) . Pre-and perinatal exposure to DEHP in rodents results in decreased testosterone production and anogenital index Parks et al., 2000) , increased nipple retention , hemorrhagic testes Nardelli et al., 2017) , and multinucleated gonocytes in the seminiferous chords Nardelli et al., 2017; Parks et al., 2000) in male pups.
Information on the impact of early life exposure to DEHP in the adult remains limited. In utero and lactational exposure to DEHP in rat models has been reported to result in either unchanged (Akingbemi et al., 2001) , increased or decreased (Culty et al., 2008; Martinez-Arguelles et al., 2009 ) testosterone levels in the adult male. Such changes are sometimes associated with decreased sperm production Dorostghoal et al., 2012) and testicular histological changes and lesions Culty et al., 2008; Dorostghoal et al., 2012) , but the underlying mechanisms are still unclear.
The growing body of evidence in support of the deleterious effects of phthalates has prompted public health authorities to regulate their use in specific applications, triggering a search for safer replacements. For example, 1,2-cyclohexane dicarboxylic acid diisononyl ester (DINCH) was first introduced to the European market in 2002, received final approval from the European Food Safety Authority in 2006, and has been marketed as a safe replacement for DEHP ever since. Exposure to DINCH is now widespread, as assessed by increased urinary levels of DINCH metabolites (Giovanoulis et al., 2016; Silva et al., 2013) . However, recent reports identify DINCH as a bioactive compound (Nardelli et al., 2015) , a potent metabolic disruptor (Campioli et al., 2015) , and a potential endocrine disruptor (Boisvert et al., 2016; Campioli et al., 2017; Nardelli et al., 2017) , raising concerns about its possible impact on public health.
In previous studies, we used a 4-step approach to identify greener replacements for DEHP with desirable plasticizing properties, biodegradability, minimal leaching, and fewer deleterious effects. We identified 2 candidate compounds, 1,4-butanediol dibenzoate (BDB) and dioctyl succinate (DOS), that did not cause significant physiological perturbations in several immortalized cell lines or after acute exposure in vivo (Albert et al., 2018; Boisvert et al., 2016; Nardelli et al., 2015) . Recently, we demonstrated that in utero and lactational exposure to BDB and DOS did not produce the phenotypes described after exposure to DEHP from gestational day (GD) 8 to post-natal day (PND) 3, 8, or 21 (Nardelli et al., 2017) . Here, we sought to investigate the consequences of in utero and lactational exposure to BDB and DOS on the adult male rat reproductive function, in a comparative study with DEHP and DINCH.
MATERIALS AND METHODS
Chemicals and reagents. DEHP was purchased from Sigma-Aldrich Corporation (CAS #117-81-7; Cat #80030, St. Louis, MO). DINCH (CAS #474919-59-0 and 166412-78-8) was purchased from BASF Canada (Mississauga, ON). BDB (CAS #19924-27-2) and DOS (CAS #14491-66-8) were synthesized as previously described (Erythropel et al., 2013; Firlotte et al., 2009; Kermanshahi-pour et al., 2009) , and their purity was determined to be 99% by NMR analysis. Chemicals were stored in a vacuum chamber with desiccant at room temperature until mixed with corn oil on each day of treatment (Catalogue #C8267; Lot#MKBN5383V, SigmaAldrich).
Animals. All manipulations and terminal procedures were approved by the McGill University Animal Care Committee (protocol #7317). Mating and treatments were done as described in Nardelli et al. (2017) . In brief, virgin female and proven-breeder male Sprague Dawley rats were purchased from Charles River Laboratories (St-Constant, Quebec, Canada) and mated on the morning of proestrus. The next morning, sperm-positive females were placed in individual cages; this was considered GD 0. On GD 8, pregnant dams were randomly assigned to a treatment group, weighed and administered doses of 30 or 300 mg/kg of DEHP, DINCH, BDB, or DOS by gavage; control animals were administered 1 ml of vehicle (corn oil). The lower dose (30 mg/kg) is representative of high human exposure to DEHP (U.S. Food and Drug Administration, 2002) with an adjustment for interspecies metabolism (Nair and Jacob, 2016) , and the higher dose (300 mg/kg) was selected based on previous literature that reported deleterious reproductive outcomes following exposure to DEHP during gestation and lactation (Gray et al., 2009) . 15-19 dams per group were treated daily across 3 cohorts, except on the day of delivery, until pups were weaned at PND 21. Animals were maintained on a 12-h light/dark cycle and provided food and water ad libitum. At PND 90, 1 male per litter was euthanized by CO 2 asphyxiation followed by cardiac puncture using a 10 ml syringe with 21 G 1-1/2-in. needle. Whole blood was collected in a BD Vacutainer SST tube (Becton, Dickinson and Company, Mississauga, ON) by negative pressure. The tubes were inverted several times and allowed to clot at room temperature for 30 min. To isolate serum, tubes were spun at 1000 Â g in an Allegra-X 15R benchtop centrifuge (Beckman Coulter, Pasadena CA) at 4 C with a SX4750 swinging bucket rotor.
Serum was aliquoted and kept at À80 C until further use.
Organs were collected, weighed, flash frozen in liquid nitrogen, and stored at À80 C for further RNA extraction and sperm counts.
Sperm head counts. 5-10 mm 3 portions of frozen testes were thawed on ice and weighed. Frozen epididymides were separated into 2 parts (caput-corpus and cauda) and weighed. Samples were homogenized in 5 ml of 0.9% sodium chloride, 0.1% thimerosal, and 0.05% Triton X-100 using the Polytron PT10-35GT (Kinematica Inc, Bohemia, NY) at 20 000 rpm for 2 intervals of 15 s separated by a 30-s interval. Sperm heads were counted using a hemocytometer (Hausser Scientific, Horsham, PA). Daily sperm production was calculated as described in Robb et al. (1978) .
Computer-assisted sperm analysis (CASA). The motility of spermatozoa was measured by CASA, as previously described (Zubkova and Robaire, 2004 RNA extraction. RNA was extracted from entire testes using the Qiagen RNEasy Mini Kit (Qiagen, Toronto, ON). In brief, frozen testes were pulverized to a thin powder using a chilled mortar and pestle. Approximately 30 mg of powder were placed in 1 ml of RLT buffer supplemented with ß-mercaptoethanol and mechanically disrupted using a rotor-stator homogenizer (Polytron PT10-35GT, Kinematica Inc.) at 20 000 rpm for 20 s. Homogenates were further processed with a QIAshredder column (Qiagen), and RNA was isolated as per the manufacturer's instructions. RNA quality was measured using a NanoDrop 2000 Spectrophotometer (Thermo Fisher), with 260/280 and 260/230 absorbance ratios comprised between 1.9-2.1 and 2.0-2.2, respectively.
Microarrays. RNA (100 ng) was labeled with Cy3 using the Agilent One Color Low Input Quick Amp kit and hybridized on arrays using the SurePrint G3 Rat Gene Expression 8x60K microarray kit (Agilent Technologies, Santa Clara, CA) as per manufacturer's instructions. All arrays were confirmed by the manufacturer to be from the same batch. Arrays were done using RNA from the testes of 6 animals from independent litters for each treatment group and read on an Agilent SureScan Microarray Scanner G2600D. The resulting data were analyzed using GeneSpring version 14.9 (Agilent Technologies). Data were normalized using percentile shift normalization to the 75th percentile. Following quality control using principal component scores on all arrays, 1 sample was removed in the DINCH 30 group. Transcripts affected by more than 1.5-fold were determined using a moderated t test and Benjamini-Hochberg FDR correction for each treatment. The microarray data have been uploaded to Gene Expression Omnibus (accession number GSE110553). The biological relationships between transcripts were analyzed using Ingenuity Pathway Analysis, version 01.12 (42012434).
RT-qPCR. We identified 6 genes of interest to be validated (Supplementary Table 1 ) from the microarray data. RNA from whole testis was converted to cDNA using the QuantiTect Reverse Transcription Kit (Qiagen), as per the manufacturer's instructions. Gene expression was quantified using the QuantiTect SYBR Green PCR Kit (Qiagen) using the StepOne Plus Real Time PCR System (Applied Biosytems, Foster City, CA) with the following thermal conditions: initial heat activation for 15 min at 95 C, followed by 50 cycles of denaturation for 15 s at 94 C, annealing for 30 s at 55 C, and extension for 30 s at 72 C.
Serial dilutions of whole testis RNA pooled from animals from all treatment groups were used as an internal reference and to create standard curves for primer efficiency and template concentration optimization. Each gene was amplified in triplicate from 6 independent samples for each treatment group. Relative levels of gene amplification compared with the control group and housekeeping gene, Ppia, were calculated using StepOnePlus Software (version 2.1). A melt curve was systematically generated to ensure the specificity of the PCR reaction.
Statistical analysis. Significance was determined by ANOVA followed by Dunnett's post hoc test. Outliers due to biological differences have not been removed from any of the data. Statistical calculations were generated using GraphPad Prism 6.07 (GraphPad Software, La Jolla, CA).
RESULTS

Overall Health and Androgen-Sensitive Organ Weights
Maternal and offspring overall health data were previously published in Nardelli et al. (2017) . In brief, there was no significant effect of the treatments on maternal weight gain or general health except for a significant decrease in heart weight after exposure to 300 mg/kg/day DEHP. Litter sizes, offspring viability, and postnatal growth remained unchanged by treatment. Animals were weighed and necropsied at PND 90 to assess whether exposure to the treatments altered general health. In utero and lactational exposure to DEHP, DINCH, BDB, and DOS did not alter body weight in adult males. This was also the case for the weights of the heart, lungs, liver, spleen, and kidneys (Supplementary Table 2 ). Exposure to 300 mg/kg/day DEHP produced a significant increase in paired epididymides weight (p ¼ .02), but other androgen-responsive and reproductive tract organs, including paired testes and seminal vesicles, were unaffected by the treatment (Figure 1 ).
Hormonal Measurements
Serum from males from 7 to 11 independent litters was assessed for testosterone, LH, and FSH concentrations to determine whether early life exposures disrupt hormonal function in adult males (Figure 2) . None of the treatments significantly altered these hormones. The ratio of testosterone to LH, a measure for possible compensated Leydig cell failure, also remained unaffected ( Figure 2C ).
Sperm Count and Motility
Testicular and epididymal sperm heads were counted to further investigate the effects of in utero and lactational exposure to DEHP, DINCH, and candidate replacement plasticizers. There were no significant effects on sperm counts in the testis, combined caput and corpus epididymides, or cauda epididymidis of exposed animals (Figs. 3A-C). Daily sperm production was unaltered by the treatments ( Figure 3D ). Immediately following necropsy, cauda sperm motility was also assessed using CASA. None of the treatments significantly altered sperm motility (Table 1) .
Testicular Gene Expression Analysis
The consequences of perinatal exposure to our candidate compounds was assessed on global testicular gene expression to provide additional insights into their possible biological effects and to identify relevant mechanisms of action that could contribute to an increase in epididymal weight observed after exposure to DEHP. Using single-color microarrays, gene expression was analyzed in 6 independent PND 90 adult males per treatment group. Figure 4A depicts the overall relationship between transcript responses to all treatments using principal component analysis (PCA). This exploratory multidimensional data mining procedure converts a set of observations of possibly correlated variables into a set of values of linearly uncorrelated variables called principal components. Treatments producing similar gene expression responses are plotted in close proximity. Here, PCA analysis described three major components representing 23.66 (x-axis), 17.07 (y-axis), and 13.45% (z-axis) of the variance among all samples. Exposure to 30 mg/kg/day BDB or DOS produced expression profiles that clustered closely to that of corn oil (grey circle, Figure 4A ); at the same dose, both DEHP and DINCH displayed profiles that were isolated and distant from this grouping. At 300 mg/kg/day, DEHP, DINCH, and BDB clustered together and further away from corn oil along the third component, while DOS presented a more isolated profile along the first and second components.
Independent statistical comparisons were used to identify the numbers of transcripts that were significantly differentially expressed, with a fold-change threshold of 1.5, between corn oil and each individual treatment ( Figure 4B ). In the 30 mg/kg/day treatment groups, DEHP, DINCH, BDB, and DOS significantly altered the expression of 12, 19, 3, and 15 transcripts, respectively. Exposure to 300 mg/kg/day DEHP produced the greatest effect, with 55 affected transcripts (26 upregulated and 29 downregulated). Comparatively, at an equivalent dose, DINCH significantly altered 14 transcripts, BDB altered 27 transcripts, and treatment with DOS produced no significant effect.
Venn diagrams in Figure 4C represent the overlap between significantly altered transcript sets for all treatments at a given dose. At both 30 and 300 mg/kg/day, BDB and DOS shared no differentially expressed transcript with DEHP or with each other. At 30 mg/kg/day, DINCH and DOS both significantly upregulated the expression of Upk3bl (uroplakin 3b-like protein), at foldchanges of 1.9 and 2.0, respectively. At 300 mg/kg/day, DEHP and DINCH both downregulated the expression of Hpgds by fold-changes of 1.7 and 1.6, respectively, and Ly6g6f (lymphocyte antigen 6 family member G6F) by fold-changes of 1.9 and 1.7, respectively. Finally, at 300 mg/kg/day, both DINCH and BDB downregulated the expression of HS3ST3A1 (heparan sulfateglucosamine 3-sulfotransferase 3A1) by 2.0 and 2.1, respectively, as well as the expression of the LOC100910837 loci (olfactory receptor 2AK2-like) by fold-changes of 1.7 and 1.5, respectively. Commonalities between doses for each treatment were quite limited. Exposure to 30 and 300 mg/kg/day DEHP significantly upregulated the expression of Xkr9 (XK, Kell Blood Group Complex Subunit-Related Family, Member 9) by 3.3-and 3.1-fold, respectively, and downregulated the expression of mitogen activated protein kinase 4 (Mapk4) by 1.7-and 1.5-fold, respectively. Overall, the limited overlap between treatments suggests that our candidate compounds do not share key mechanisms of action with DEHP and DINCH.
For each treatment, we further investigated the transcripts that were the most significantly altered based on absolute fold change (Table 2) . To understand the biological relationships underlying such gene expression changes, the transcripts that were significantly altered by 1.5-fold or more were imported into Ingenuity Pathway Analysis. Pathways that were predicted to be significantly affected by the treatment and related transcripts are listed in Supplementary Table 3 . While these pathways were not specifically predicted to be activated or inhibited (null z-score) due to the limited number of transcripts on these lists, they may identify gene enrichment for important physiological pathways within our datasets. Based on the latter information, and considering the transcripts with highest absolute fold changes and their role relative to testicular function, we selected 6 targets of interest to be validated by RT-qPCR ( Figure 5) .
Interestingly, among all transcripts displaying modified expression, several were related to estrogen function and signaling. Hence, the nuclear receptor NR5A2, which plays a predominant role in reverse cholesterol transport and steroidogenesis (Pezzi et al., 2004; Sirianni et al., 2002) , was downregulated by 7.3-fold after exposure to 30 mg/kg/day DEHP (Table 2) . Validation with RT-qPCR confirmed this downregulation and revealed that Nr5a2 expression was also targeted by exposure to 300 mg/kg/day DEHP and by 30 mg/kg/day DINCH and BDB ( Figure 5A) . Lactotransferrin, the expression of which is dependent on estrogen (Teng, 2006) , was also of interest in this context. Microarray data revealed that exposure to 300 mg/kg/day BDB downregulated the latter by 2.1-fold (Table 2) . Validation by RT-qPCR not only confirmed this effect, but also revealed a Figure 1 . Androgen-sensitive organ weights in PND 90 male rats following in utero and lactational exposure to DEHP, DINCH, BDB, or DOS. Data are standardized to 100 g body weight (bw) except for testes, which are encapsulated organs.
Significance was determined by one-way ANOVA corrected by Dunnett's multiple comparison test; n ¼ 8-11 animals from independent litters per group; *p < .05. stronger downregulation of Ltf by 300 mg/kg/day DEHP ( Figure 5B ). Finally, exposure to 30 mg/kg/day DEHP led to a significant 1.8-fold downregulation of Runx2 (runt-related factor 2) expression ( Table 2 ). The latter regulates the expression of many steroid hormone-responsive genes in osteoblasts, and is regulated itself by estrogens at the transcriptional level (Teplyuk et al., 2009) . qRT-PCR analysis did not reveal a statistically significant effect on the expression of this gene ( Figure 5C ).
Other targets of interest included the hematopoietic prostaglandin D-synthase HPGDS, which is involved in inflammatory responses, and was downregulated by 1.7 and 1.6-fold after exposure to 300 mg/kg/day DEHP and DINCH, respectively (Table 2) . Because many putative endocrine disruptors have been shown to disrupt prostaglandin synthesis, we further assessed Hpgds expression by RT-qPCR but found no significant effect by any of the treatments ( Figure 5D ). Mapk4 was downregulated by 1.7 and 1.5-fold after exposure to 30 and 300 mg/kg/ day DEHP, respectively ( Table 2 ). The tyrosine-protein kinase SYK, also involved in the MAPK signaling cascade, was downregulated by 1.5 and 1.6-fold, respectively, after exposure to 30 mg/kg/day DINCH or 300 mg/kg/day BDB (Table 2) . However, RT-qPCR did not reveal statistically significant differences in the expression of these genes (Figs. 5D and 5E ).
DISCUSSION
In a previous study, we demonstrated that in utero and lactational exposure to DEHP produced classically described endocrine-disruptive phenotypes such as a decreased Number of uniquely mapped transcripts significantly up or downregulated by more than 1.5-fold determined by moderated t test and Benjamini-Hochberg FDR correction (p > .05); (C) Venn diagrams representing commonalities in differential gene expression between treatments at 30 and 300 mg/kg/day, respectively. All data were generated using n ¼ 5-6 male rats from independent litters. anogenital index and increased multi-nucleated gonocytes at PND 3, as well as hemorrhagic testes at PND 8 (Nardelli et al., 2017) . In comparison, exposure to BDB and DOS did not produce any significant effect on these endpoints. Here, we explored the impact of in utero and lactational exposure to DEHP, DINCH, BDB, and DOS in adult offspring. This study provides evidence that perinatal exposure to DINCH, BDB, and DOS produces no significant effects on organ weights, serum gonadotropin, and testosterone levels or sperm quality in the adult. In addition, we demonstrate that exposure to one green plasticizer, DOS, has fewer effects on testicular gene expression than DEHP, and identify estrogen signaling in the testis to be a potential longterm target of DEHP. Several studies have reported significant decreases in testicular or seminal vesicle weights in the adult male resulting from perinatal DEHP exposure. These effects were observed solely after exposure to relatively high doses of DEHP. Exposure to 938 or 1250 mg/kg/day DEHP from GD 14 to PND 0 produced a higher incidence of testicular atrophy (Culty et al., 2008) , while exposure to 500 mg/kg/day DEHP from GD3 to PND 21 produced a significant decrease in testicular weight (Dorostghoal et al., 2012) . In other studies, exposures to 405 mg/kg/day DEHP from GD 6 to PND 21 or to 500 mg/kg/day DEHP from GD 0 to PND 21 (Dalsenter et al., 2006) produced significant decreases in seminal vesicle weights; these effects were not associated with changes in testicular weight. To the best of our knowledge, there are no studies showing an alteration of adult reproductive organ weights after in utero and lactational exposure to DEHP at doses below 405 mg/kg/day. Consistent with these findings, we did not observe a significant effect of DEHP exposures at 30 and 300 mg/kg/day on testicular or seminal vesicle weights. However, exposure to 300 mg/kg/day DEHP did produce a significant increase in paired epididymal weight. Importantly, we did not find any significant effect of exposure to DINCH, BDB, or DOS on androgen-dependent organ weights.
We measured serum steroids and gonadotropins to investigate whether exposure to our candidate compounds would affect steroidogenesis. Testosterone, LH and FSH levels remained unaffected by all treatments. The ratio of testosterone to LH a measure for possible compensated Leydig cell failure, remained unaffected as well; this ratio was decreased in adult rats following perinatal exposure to dibutyl phthalate, a potent antiandrogen (Kilcoyne et al., 2014) . The literature on the long-term consequences of perinatal exposure to DEHP on steroidogenesis in males remains quite scarce. Exposure of Long Evans dams to 100 mg/kg/day DEHP from GD 12 to GD 21 produced inhibitory effects on testosterone and LH levels in the male offspring that were no longer apparent at PND 90 (Akingbemi et al., 2001) . Two other studies report significant decreases in circulating testosterone levels at PND 60 following in utero exposure of Sprague Dawley dams to doses of DEHP starting at 100 mg/kg/day (Culty et al., 2008; Martinez-Arguelles et al., 2009) ; here, the treatment windows, GD 14 to PND0 or GD 14 to GD 19, respectively, were limited to fetal life. In contrast, the male offspring of Wistar dams showed increased testosterone levels at PND 90 after exposure to 0.045, 0.405, or 405 mg/kg/day DEHP from GD 6 to PND 21 . These divergences seem to be highly dependent on the rat strain, the dose and the window of exposure used, and call for a deeper exploration of the long-term consequences of exposure to DEHP. DINCH and our candidate compounds, BDB and DOS, did not affect testosterone, LH or FSH concentrations in serum.
We assessed sperm production at PND 90 to investigate whether exposure to our candidate compounds affects spermatogenesis in the adult. None of the treatments significantly affected testicular or epididymal sperm head counts or cauda sperm motility. In a previous study, in utero and lactational exposure to DEHP has been reported to reduce daily sperm production 19%-25% in relation to control in animals exposed to 15, 45, 135, or 405 mg/kg/day . Reduced sperm counts were also observed in the male offspring of dams exposed to 100 or 500 mg/kg/day DEHP from GD 3 to PND 21 (Dorostghoal et al., 2012) . Similarly, exposure to 500 mg/kg/day DEHP from GD 0 to PND 21 significantly reduced sperm production in adult males (Dalsenter et al., 2006) ; however, these effects were not observed at lower doses. The latter 3 studies have in common the use of Wistar rats. In our study, we used Sprague Dawley rats, which have been shown to be more resistant to some endocrine disrupting compounds in different experimental settings (Abuelhija et al., 2013; Kacew and Festing, 1996) , including to diethylstilbestrol (Shellabarger et al., 1978) . Such strain differences in susceptibility may contribute to the absence of effects on sperm counts in our experiments.
Using toxicogenomics, we determined whether our candidate compounds would produce detrimental effects on testicular gene expression in the adult in comparison to DEHP. We observed that in utero and lactational exposure to 300 mg/kg/day DEHP produced the most substantial effect on adult testicular gene expression, while the overall gene expression profile after exposure to BDB and DOS was closer to that of corn oil. We also identified several related genes presenting altered expression following exposure to DEHP, DINCH, or BDB. Based on significance, fold changes and pathway analysis, we narrowed down our list of targets to 6 transcripts, and validated our data using RT-qPCR.
Interestingly, we found 3 of these transcripts to be associated with estrogens. We identified the expression of Nr5a2 to be significantly altered after exposure to both doses of DEHP, and 30 mg/kg/day DINCH and BDB. Also called liver receptor homologue-1 (LRH-1), NR5A2 is an orphan nuclear hormone receptor closely related to steroidogenic factor 1 (SF1). It is expressed in several steroidogenic tissues in many species, and has been hypothesized to play a critical role in development and function of the endocrine and reproductive systems (Sirianni et al., 2002) . NR5A2 has been demonstrated to regulate the transcription of genes encoding steroidogenic enzymes, Figure 5 . Gene expression quantification by RT-qPCR for selected transcripts following in utero and lactational exposure to DEHP, DINCH, BDB or DOS. Relative levels of gene amplification compared with the control group and housekeeping gene Ppia were calculated following the DDC t method. Significance was determined by one-way ANOVA corrected by Dunnett's multiple comparison test; n ¼ 6 biological replicates plated in triplicate; **p < .01; ****p < .0001. more specifically aromatase (Pezzi et al., 2004) . In the adult male, aromatase activity is higher than at any other age (TsaiMorris et al., 1985) . Furthermore, exposure to 300 mg/kg/day DEHP and BDB produced a significant decrease in Ltf expression. The secretion in reproductive tissues of lactotransferrin, a multifunctional glycoprotein, is estrogen-dependent (Teng, 2006) . While its role in the male reproductive tract remains largely unknown, it is found in the testis, epididymis, vas deferens, and prostate (Yu and Chen, 1993) . Lactotransferrin is also abundant in seminal fluid and is believed to be directly correlated to gonadal function and sperm concentration in several species (Kikuchi et al., 2003a, b) . Finally, the significant downregulation of Runx2 by DEHP is also in agreement with a dysregulation of estrogen signaling in the testis. There are indeed several examples of gene regulatory interplay between Runx2 and estrogens (Teplyuk et al., 2009) , notably its role in the regulation of steroidogenic enzyme Cyp11a1.
Estrogens have profound implications in testicular and epididymal development and function, and therefore on male fertility (Cooke et al., 2017; O'Donnell et al., 2001) . In adult males, estrogen administration or deficiency may affect the maintenance of the hypothalamo-pituitary-testis axis (O'Donnell et al., 2001; Robaire et al., 1979) . Testicular estrogens have also been shown to play a role in the regulation of luminal fluid reabsorption by the epithelial cells lining the efferent ductules (Hess et al., 2011) . Finally, many studies provide indirect evidence for a role of estrogen in spermatogenesis involving germ cell proliferation, differentiation, and maturation of spermatids, as well as germ cell survival and apoptosis (reviewed in Carreau and Hess, 2010) . Our gene expression data point toward a subtle but significant dysregulation of estrogen function in the testis after exposure to DEHP, and to a lesser extent to DINCH and BDB. Using high performance liquid chromatography/mass spectrometry, serum estradiols were below levels of detection in this study (data not shown). However, the increased epididymal weight we observed after exposure to 300 mg/kg/day DEHP is consistent with a potential impairment of fluid reabsorption by the efferent ductules that might be related to estrogen signaling.
This study provides evidence that in utero and lactational exposures to our candidate compounds, BDB and DOS, as well as exposure to DINCH, do not produce significant alterations in adult male reproductive function. However, our data indicate that exposure to DEHP and, to a lesser extent, exposure to DINCH and BDB could produce subtle but significant alterations of estrogen signaling in the adult testis. These data need to be placed in the context of exposure to multiple endocrine disruptive compounds: gene expression modifications that are observed more than 2 months after exposure has ceased may suggest that exposure to multiple compounds throughout life may have long-lasting effects on adult male testicular function. Importantly, exposure to DOS did not produce significant changes in the expression of the estrogen signaling targets we studied, confirming its potential as a substitute for DEHP.
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